Treace Medical Concepts TMCI
NASDAQ TMCI
$4.46 -0.10 (-2.19%)
At close: Aug 20, 2026 · 4:00 PM EDT

Treace Medical Concepts (TMCI) Share-based Compensation Growth (3y) (2023 - 2026)

Treace Medical Concepts (TMCI) Share-based Compensation Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (3y) (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 8.37%
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn -28.31%
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 8.20%
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 13.19%
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 4.11%
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -0.59%
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 17.13%
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 36.49%
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 3.40%
10 Treace Medical Concepts 290.12 Mn 244.50 Mn 35.61 Mn 21.58%

Historic Data

Download Data
DateValue
Jun 30, 2026 21.58%
Mar 31, 2026 43.97%
Dec 31, 2025 -130.64%
Sep 30, 2025 52.19%
Jun 30, 2025 69.60%
Mar 31, 2025 83.41%
Dec 31, 2024 82.16%
Sep 30, 2024 111.16%
Jun 30, 2024 97.49%
Mar 31, 2024 164.13%
Dec 31, 2023 129.63%
Sep 30, 2023 246.32%
Jun 30, 2023 143.85%
Mar 31, 2023 134.41%